Fig. 2From: Recent advances in systemic therapy for hepatocellular carcinomaCurrently approved drugs for advanced HCC and timeline of pivotal clinical trials. The lines along the timeline indicate the time from the actual study start to FDA approval. The red boxes represent first-line therapies, and the green boxes represent second-line therapiesBack to article page